ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,208Medicare Part D Prescriptions Filled, Including Refills

Rank: 44 out of 546

$706K Total Retail Price of All Prescriptions

Rank: 22 out of 546

338 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 338 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

12% of this provider’s 338 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 6,189 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$86 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
LISINOPRIL 310 275 1 1
FUROSEMIDE 265 228 2 5
OMEPRAZOLE 262 206 3 4
SIMVASTATIN 251 206 4 2
METOPROLOL TARTRATE 235 196 5 6
WARFARIN SODIUM 203 177 6 13
METFORMIN HCL 187 114 7 10
AMLODIPINE BESYLATE 184 160 8 9
LEVOTHYROXINE SODIUM 182 163 9 3
HYDROCODONE-ACETAMINOPHEN 180 99 S3 10 8
ATORVASTATIN CALCIUM 168 131 11 11
HYDROCHLOROTHIAZIDE 136 111 12 7
ATENOLOL 128 90 13 12
TRAMADOL HCL 123 79 14 19
GLYBURIDE 114 79 R 15 45
ZETIA 109 76 16 81
LOVASTATIN 108 84 17 22
CRESTOR 102 73 18 36
PAROXETINE HCL 98 80 19 43
SERTRALINE HCL 98 93 19 14
ZOLPIDEM TARTRATE 96 64 21 26
ISOSORBIDE MONONITRATE ER 92 83 22 32
SPIRIVA 85 85 23 28
ROPINIROLE HCL 85 73 23 64
MELOXICAM 85 69 23 58
GABAPENTIN 82 69 26 16
SUCRALFATE 75 59 27 137
METOPROLOL SUCCINATE 71 71 28 17
ALLOPURINOL 67 46 29 41
TAMSULOSIN HCL 64 48 30 35
CARVEDILOL 62 42 31 56
PANTOPRAZOLE SODIUM 61 53 32 18
DIOVAN 60 48 33 65
OXYCODONE HCL-ACETAMINOPHEN 60 26 S2 33 101
CYMBALTA 57 27 35 37
PREDNISONE 56 52 36 29
NEXIUM 56 41 36 52
CELEBREX 55 35 38 122
AZITHROMYCIN 54 43 39 55
OXYCODONE-ACETAMINOPHEN 54 25 S2 39 54
DILTIAZEM 24HR ER 53 34 41 200
NITROGLYCERIN PATCH 51 51 42 117
LYRICA 51 30 42 69
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 13, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.